Ex cell Bio Biotechnology (Taicang) Co., Ltd. ("Yikesai Bio") officially completed a new round of nearly 100 million yuan in financing. This round of financing was led by Yonghua Investment, followed by Zhongguancun Development Frontier Enterprise Investment Fund, Suzhou Yajie Angel Investment, Yao Kun Technology and other institutions, mainly used to build serum-free medium GMP production workshops, and further expand overseas serum factories to improve Production capacity, accelerate the construction of overseas marketing network, focus on the development direction and goals of Ex cell Bio in the next three to five years, and enhance the company's core competitiveness.
Chen Xu, Founder and President of Ex cell Bio, said: "First of all, I sincerely thank Yonghua, China Development, Yajie and Yao Kun. This round of financing is a milestone for Ex cell Bio and will help us achieve faster, better, and more Big development. Secondly, this round of financing is also the capital market’s high recognition of Ex cell Bio’s past achievements, development strategy and future prospects. Looking at the present, the blue ocean of biomedicine is magnificent and bred with infinite energy. With this round of financing, Ex cell Bio will focus on the upstream tool industry of biomedicine with continuous innovation and professionalism, and provide high-quality products such as serum-free medium, fetal bovine serum and functional identification kits for biomedicine, gene cell therapy, stem cell industry and scientific research customers And services to create cell culture “Chinese core” products, solve the “stuck neck” problem of China’s biomedical industry’s key raw materials relying on imports, and contribute to accelerating the development of China’s life science industry."
About Ex cell Bio
Ex cell Bio Biotechnology (Taicang) Co., Ltd. was founded in 2013, derived from the well-known brand "Genetimes" (Genetimes) in China's life science industry founded in 1998. It is one of China's largest suppliers of cell culture reagents and consumables. It is one of the leading companies in China's upstream core raw materials for biomedicine, China's first International Serum Industry Association (ISIA) member unit, a national high-tech enterprise, and Jiangsu Engineering Technology Research Center for Cell Therapy Medium and Genetic Testing Reagents. The company focuses on providing high-quality products and technical services such as serum, serum-free media and functional identification kits for customers in the fields of biopharmaceuticals, gene cell therapy, precision medicine and scientific research, and implements domestic substitution of imports. The company's vision is to become a life science enterprise with world influence!